ADVERTISEMENT

Senate panel chief calls two no-show Pharmally execs in probe 'Senate fugitives'

Published Oct 28, 2021 04:25 pm

Senator Richard Gordon on Thursday branded two executives of Pharmally Pharmaceutical Corporation “Senate fugitives” after they stopped participating in the Senate Blue Ribbon Committee’s ongoing investigation into the alleged overpriced COVID-19 supplies.

Gordon said the actions of Pharmally’s Mohit Dargani, corporate secretary and treasurer and his sister, Twinkle Dargani, the company’s president, are contemptuous, especially their refusal to submit the documents subpoenaed by the Senate panel.

Both siblings have yet to be arrested since the October 19 hearing of the panel. Both were a no-show in Thursday’s hearing.

“Again, contemptuous yung ginawa nila. Habang siya ay nakasalang, si Mohit Dargani, nung sinabi namin na sila ay pako-contempt (what they did was contemptuous. While he, Mohit Dargani was being questioned, when he was told he would be cited for contempt) that would have been a reason for him to say magsasalita na po ako (I will speak up),” Gordon said during the resumption of the Senate blue ribbon panel’s investigation.

Gordon was recalling what happened during the Oct. 19 hearing, where the Darganis left the panel’s hearing that is being held virtually.

The Senate has cited the Darganis for contempt for failing to submit the documents asked by the panel and has ordered for them to be detained in the Senate. However, the Office of the Senate Sergeant at Arms has yet to find them.

“Ano po ang ginawa? Imbes na magsalita, nawala na lang po sa ating virtual at hindi na po sumagot. Umiskapo na po at naging fugitive sa Senado at hindi na sila nagpakita silang magkapatid (What did they do? Instead of making disclosures, they just vanished in our virtual hearing, and they have not responded. They have escaped and became fugitives of the Senate and both siblings did not show up anymore),” he added.

Pharmally remains at the center of the Senate blue ribbon’s investigation for bagging over P8-billion in contracts from the Department of Budget and Management’s Procurement Service (DBM-PS) in 2020.

In a statement last week, Mohit Dargani slammed the blue ribbon panel for treating Pharmally officials “like criminals whose lives aren’t worthy of living anymore.”

Gordon responded to Dargani’s accusation by saying he should come forward and submit the pertient documents asked of them by the Senate panel if he wants to clear their name.

“But while they continue to hide, people will believe they are as guilty of what they are accused of,” the senator pointed out in a statement last week.

Related Tags

Senate probe Senate blue ribbon committee DBM-PS Pharmally Pharmaceutical overpriced COVID-19 supplies richard gordon Darganis
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.